Page 64 - 2018食藥署年報(英文版)

Implementation Measures

In order to reinforce the management over controlled drugs and to prevent them from

entering the market and trigger abuse, the Administration convenes the “MOHW Controlled Drug
Review Committee” once every six months to assess the necessity to include emerging substances
that have been abused internationally or recently under control. We also provide the Ministry of
Justice with advice on the addition and revision of items listed as controlled at the same time.
The 35 and 36 MOHW Controlled Drug Review Committee had been held on June 21,
th
th
2017, and December 19, 2017, respectively to discuss listing of emerging drugs recently included
by the Ministry of Justice under control that is needed for scientific purpose as controlled drugs
and classifying them accordingly. Then, they are reported to the Executive Yuan according to the
administrative procedure for the latter to announce their listing under control.

Outcomes and Benefits

A total of 14 controlled drugs were announced to have been added or revised in 2017.
Detailed items and classes they belong to are shown in Table 4-1. None of the controlled
substances mentioned above have been approved for use medically in the country at the moment.
To meet scientific needs, they are listed as controlled drugs reflective of their existing classes as
drugs for reinforced management over their whereabouts and for preventing against misuse or
abuse that jeopardize national health.

Table4-1 2017 Addendum to Classification of Controlled Drugs

Date of
amendment Schedules Promulgate the names of the controlled drugs Descriptions

Methoxymethamphetamine or MMA, including 3 isomers (i.e. 2-MMA,
January 5 Schedule 2
3-MMA and 4-MMA)
CNS stimulant, a
type of Amphetamine
chemical synthetics.
2-Methylaminopropyl, Benzofuran or MAPB, including 6 isomers (i.e.
January 5 Schedule 2
2-MAPB, 3-MAPB, 4-MAPB, 5-MAPB, 6-MAPB and 7-MAPB)

Chloromethyl carbamazone 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone
June 23 Schedule 2
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, Alpha-PVP
CNS stimulant, a
type of Cathinone
chemical synthetics.
Bromomethcathinone (BMC) or Methyl-α-pyrrolidinohexiophenone
December 13 Schedule 2
(MPHP), including 3 isomers (i.e. 2-MPHP, 3-MPHP and 4-MPHP)

62